Home >

Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

Well. I have completed my year as ASCO President, as of Monday, and now get to return to obscurity. Or, as one of my colleagues told me, surveying my palatial digs in the Conrad Hilton Suite, "Next year, Motel 6 in Skokie, George." No doubt. But this year I had the opportunity to lead the world's...
The ASCO Board has embraced the concept of the Rapid Learning Health Care System (RLHS), the vision of a national digital health information system that enables sharing of data between individual health care providers and patients as well as populations of healthy individuals who are at...
There is no mistaking that the notion of hope is pervasive at the Annual Meeting. During Sunday's Plenary Session there was a nearly palpable energy in the room: Hope for what these findings might mean for our patients! Hope that these therapies may lead to better outcomes for...
As Saturday at the Annual Meeting has now come to a close, I would like to share a few thoughts:-In his Presidential Address, Dr. Sledge noted that cancer deaths are decreasing in the US; however, by the year 2030, it is projected the number of cancer deaths worldwide will exceed a staggering 11...
Greetings from the Annual Meeting!While it was difficult to narrow my selections for sessions I would attend today (a feat more challenging than navigating Chicago traffic, I think!), I am most grateful to the ePlanner technology for making the process just a bit easier!The ePlanner technology is...
You may remember a blog I wrote a few months ago commenting on an article describing cancer patients entering Phase I trials as being guilty of “unrealistic optimism” regarding their...
Last week, at Yale Surgical Grand Rounds, I heard one of the best lectures I’ve heard in a while.  It was given by my good friend, Jeff Matthews, who is currently Chair of Surgery at University of Chicago.  His Samuel Clark Harvey Memorial lecture, entitled “Truth and ...
In less than two weeks Mike Link of Stanford will be replacing me as President of our organization. He will do a great job: he is an honest, thoughtful, forthright physician whose intelligence and good sense, as well as his unique perspectives as a pediatric oncologist, will add much to our society...
I have been working on my Presidential Address in recent weeks, an address that I wanted to end by looking back to the moral center of our profession. In doing so I came across Francisco Goya’s ...
In June, I will become the 47th president of ASCO. This is an intimidating prospect for anyone—ASCO is a complex organization representing multiple subspecialties from all over the world. The membership now exceeds 30,000 individuals from private practice, academia, research, industry, and advocacy...
The last few weeks before the Annual Meeting are an increasingly frenzied period for ASCO staff and for your president. Orchestrating the meeting of 30,000 oncology professionals requires a great deal of work by staff.  There is also, inevitably, some last minute reshuffling of the scientific...
In a previous blog, I discussed “Hill Day,” the annual pilgrimage that your ASCO volunteers make to our nation's Capitol in support of federal cancer research funds. Hill Day was...
One of the more astonishing and unexpected developments of the past two decades has been the expansion of the clinical cancer research universe from a relatively few countries (the U.S., Canada, Western Europe, Japan, and Australia, to be precise) to an essentially global enterprise. This expansion...
Many thought the budget battle was over after Congress struck a deal in April to fund the government through the end of fiscal year 2011. The cancer community collectively breathed a sigh of relief when the numbers came out and the National Institutes of Health (NIH) received only a 0.8% reduction...
Two articles in the most recent New England Journal of Medicine should get you thinking about where we are as a profession.  Both have to do with prostate cancer, and while unrelated in their subject matter they both require us to address the same issue:  whom do we treat?
A few nights ago, I was invited to speak to the Board of Directors and Major Donors of the Breast Cancer Alliance. A hush came over the crowd as I described the real advances we are making in breast cancer research and treatment – how we are now able to sequence the human genome, determine genes...
I have been in the DC area the past three days and am now heading home to Indianapolis. Tuesday I spent at the National Institutes of Health campus in Bethesda, MD, where I was invited to give Grand Rounds at the NCI. Wednesday I took the Metro down to ASCO Headquarters in Alexandria, VA. Today (...

Pages


Advertisement